Sign in
IMMB Stock Price, Chart, Stats & News
Immunotech Laboratories, Inc.
Save
Immunotech Laboratories, Inc. (IMMB) does not currently pay a dividend.
114,993
Market cap
–
Current P/E
–
Forward P/E
IMMB chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California.
Similar securities
Based on sector and market capitalization
Report issue